MTOR and breast cancer: These findings support the hypothesis that there can be complex crosstalk between cell cycle and mitogenic signaling pathways in CRC cells, and that PIK3CA mutated CRC cells might be more dependent on the PI3K/AKT/mTOR pathway than breast cancer cells.